Veriskin

San Diego, United States Founded: 2014 • Age: 12 yrs
Tools for non-invasive skin cancer diagnosis are developed.
Request Access

About Veriskin

Veriskin is a company based in San Diego (United States) founded in 2014.. Veriskin has raised $1.68 million across 5 funding rounds from investors including HHS, National Cancer Institute and Pasadena Angels. Veriskin offers products and services including TruScore Device. Veriskin operates in a competitive market with competitors including Castle Biosciences, DermTech, AMLo Biosciences, Haut and MELAGENIX, among others.

  • Headquarter San Diego, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Legal Name Veriskin, Inc
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $1.68 M (USD)

    in 5 rounds

  • Latest Funding Round
    $3.9 M (USD), Grant

    May 24, 2021

  • Investors
    HHS

    & 5 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Veriskin

Veriskin offers a comprehensive portfolio of products and services, including TruScore Device. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Handheld tool for non-invasive, real-time skin cancer screening.

People of Veriskin
Headcount 1-10
Employee Profiles 3
Board Members and Advisors 2
Employee Profiles
People
Jurgita Jonutyte
Controller & Human Resources Manager
People
Monica Alfaro Welling
VP, Commercialization

Unlock access to complete

Board Members and Advisors
people
Carl Edman
Co-Founder & Board Member
people
Eugene Tu
Co-Founder & Board Member

Unlock access to complete

Funding Insights of Veriskin

Veriskin has successfully raised a total of $1.68M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $3.9 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round Grant — $3.9M
  • First Round

    (01 May 2016)

  • Investors Count 6
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2021 Amount Grant - Veriskin Valuation

investors

May, 2021 Amount Seed - Veriskin Valuation Pasadena Angels , ASAP
Nov, 2020 Amount Seed - Veriskin Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Veriskin

Veriskin has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, National Cancer Institute and Pasadena Angels. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investments are facilitated by Pasadena Angels in Southern California startups.
Founded Year Domain Location
A Montana-based network of angel investors is operated.
Founded Year Domain Location
Angel investments are made in startups across various sectors.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Veriskin

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Veriskin

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Veriskin Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Veriskin

Veriskin operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Castle Biosciences, DermTech, AMLo Biosciences, Haut and MELAGENIX, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
domain founded_year HQ Location
Adhesive patch biopsies for skin cancer detection are provided.
domain founded_year HQ Location
Prognostic tests for early-stage melanoma detection are developed.
domain founded_year HQ Location
SaaS solutions using AI for skincare businesses are provided.
domain founded_year HQ Location
Molecular diagnostic tests for skin cancer detection are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Veriskin

Frequently Asked Questions about Veriskin

When was Veriskin founded?

Veriskin was founded in 2014 and raised its 1st funding round 2 years after it was founded.

Where is Veriskin located?

Veriskin is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Is Veriskin a funded company?

Veriskin is a funded company, having raised a total of $1.68M across 5 funding rounds to date. The company's 1st funding round was a Seed of $682.34K, raised on May 01, 2016.

What does Veriskin do?

Veriskin was founded in 2014 in San Diego, United States, and operates in the medical technology sector. Non-invasive diagnostic tools for skin cancer are developed by the company, including a device that employs spectroscopy to assess pressure-induced hemodynamic variations between benign and malignant lesions. Investigations focus on applications for basal-cell carcinoma and squamous cell carcinoma, with operations centered on advancing these diagnostic technologies.

Who are the top competitors of Veriskin?

Veriskin's top competitors include DermTech, AMLo Biosciences and Castle Biosciences.

What products or services does Veriskin offer?

Veriskin offers TruScore Device.

Who are Veriskin's investors?

Veriskin has 6 investors. Key investors include HHS, National Cancer Institute, Pasadena Angels, Frontier Angels, and Ariel Savannah Angel Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available